What tirzepatide is used to treat — and what it isn't

The biggest misconception: tirzepatide is not a lifestyle shortcut

The most persistent myth about tirzepatide is that it replaces the need for dietary change. It doesn't, and the licence says so explicitly: it is indicated alongside a reduced-calorie diet and increased physical activity, not instead of them. This isn't a legal footnote to be glossed over. The trial populations (including the SURMOUNT-1 study published in the New England Journal of Medicine) all received behavioural support alongside the medicine. The weight outcomes reflect that combination, not the drug in isolation.

It's easy to see why the misconception took hold. Headlines focused on the percentage figures, which are striking. But understanding what tirzepatide treats properly means understanding that it works by reducing appetite and slowing how quickly food leaves the stomach, it changes the conditions in which you eat, not whether eating choices matter at all.

Letting go of that idea gently is worth doing early, because it shapes everything from how you approach food on treatment to how you manage the months after you stop.

The two conditions tirzepatide is licensed for in the UK

The first is weight management. The SmPC criteria for private prescribing are a BMI of 30 or above, or 27 or above with at least one qualifying weight-related condition, examples include type 2 diabetes, prediabetes, high blood pressure, obstructive sleep apnoea, high cholesterol and osteoarthritis. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. A prescriber considers the full clinical picture, so meeting the BMI number alone doesn't settle the question either way.

The second is type 2 diabetes, where tirzepatide (also branded as Mounjaro) has a separate licence to improve blood sugar control. This is distinct from the weight-management indication, though the two can overlap in the same patient.

If you're exploring tirzepatide as a treatment option, the starting point is understanding which licence applies to your situation and whether a prescriber agrees treatment is suitable. NICE recommended tirzepatide for NHS use in December 2024 under specific eligibility criteria detailed in NICE technology appraisal TA1026.

What tirzepatide is not used to treat

Tirzepatide is not licensed for cosmetic weight loss. The MHRA has stated directly that GLP-1 medicines are not assessed for quick or appearance-led weight reduction. It is not indicated for people who are a healthy weight and want to lose a small amount, and it is not recommended during pregnancy, while breastfeeding, or for anyone trying to conceive. It is not licensed for under-18s.

Conditions sometimes mentioned alongside tirzepatide (such as fatty liver disease or cardiovascular risk reduction) are not part of its current UK licence for weight management, though research continues. Semaglutide (Wegovy) has received separate approvals in those areas; tirzepatide has not. If a seller implies tirzepatide treats anything beyond its two licensed indications, that's a signal worth questioning. The NHS tirzepatide medicines page is a reliable place to check the basics.

Diet alongside tirzepatide: why it still matters

Because tirzepatide reduces appetite noticeably, some people find they're eating far less without trying. The practical risk is eating too little protein or too few nutrients overall, which can affect muscle mass and energy. Guidance on what to eat on tirzepatide consistently points toward protein-first meals, adequate hydration and fibre, not a punishing deficit on top of an already suppressed appetite.

The food choices that sit alongside tirzepatide are genuinely worth thinking through before you start, not after nausea has already put you off the kitchen. A question our prescribers hear regularly is whether there are specific foods to avoid; the short answer is that fatty, very rich or high-sugar foods tend to worsen gastrointestinal side effects, so it's worth being deliberate about what you eat rather than simply eating less of whatever happens to be there. More detail on which foods tend to work well and which to approach with caution is covered separately.

The cost of treatment is worth understanding in context too. If you're weighing up private options, our page on Eli Lilly's 2025 UK price changes explains the background clearly.

If tirzepatide sounds like it might be relevant to your situation, a free consultation with our prescribers is the right next step. Check your eligibility and start your free consultation, a real clinician reviews your answers the same day.